Calcitonin gene-related peptide (CGRP) is a mediator of vascular adaptations during hypertension in pregnancy

Trends in Endocrinology and Metabolism

Volumn 9, Issue 3, 1998, Pages 113-117

  Yallampalli, Chandrasekhar ^a   Wimalawansa, Sunil J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE;

ARTICLE; FETUS DISEASE; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; VASODILATATION;

EID: 0031958438     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00025-3     Document Type: Article

References (26)

1. Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE Preeclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine D-arginine, and steroid hormones. Hum Reprod. 10:1995;2723-2730.
2. Carter TL, Park P, Pratt K, Magno M, Mannion JD Effects of CGRPα on the migration of endothelial cells of human origin. FASEB J. 7:1993;125.
3. Datta HK, Rafter PW, Wimalawansa SJ, Chen ZP, MacIntyre I CGRP and amylin-amide display a proliferative effect on human umbilical endothelial cells and osteoblast-like osteosarcoma cell-line. Biochem Soc Transact. 18:1990;1276.
4. DiPette D, Wimalawansa SJ: 1994. Cardiovascular actions of calcitonin gene-related peptide. In Crass MF, III, Avioli LV, eds. Calcitum-regulating Hormones and Cardiovascular Function. Ann Arbor, MI, CRC Press, pp 239-252.
5. Gangula PRR, Supowit SC, Wimalawansa SJet al. Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy. Hypertension. 29:1997;248-252.
6. Gangula PRR, Wimalawansa SJ, Yallampalli C Progesterone upregulates vasodilator effects of calcitonin gene-related peptide in NG-nitro-arginine methyl ester-induced hypertension. Am J Obstet Gynecol. 76:1997;894-900.
7. Gant NF, Daley GL, Chand Set al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 52:1973;2682-2689.
8. Girgis SI, MacDonald DWR, Stevenson JCet al. Calcitonin gene-related peptide: potent vasodilator and major product of the calcitonin gene. Lancet. 2:1985;14-16.
9. Knight KB, Keith RE Calcium supplementation on normotensive and hypertensive pregnant women. Am J Clin Nutr. 55:1992;891-895.
10. Molnar M, Hertelendy F N-nitro-L-arginine, an inhibitor of nitric oxide synthesis increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol. 166:1992;1560-1567.
11. Molnar M, Suto T, Toth T, Hertelendy F Prolonged blockade of nitric oxide synthesis in gravid rats produced sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 170:1994;1458-1466.
12. Nelson SH, Steinsland OS, Suresh MS Possible physiologic role of calcitonin gene-related peptide in the human uterine artery. Am J Obstet Gynecol. 168:1993;605-611.
13. Roberts JM, Redman CWG Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 341:1993;1447-1451.
14. Rosenfeld MG, Mernod JJ, Amara SG Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 304:1983;129-135.
15. Stevenson JC, MacDonald DWR, Warren RC, Booker MW, Whitehead MI Increased concentration of calcitonin gene-related peptide during normal human pregnancy. Br Med J. 293:1986;1329-1330.
16. Tabrizchi R, Triggle CR Actions of L-and D-arginine and NG monomethyl-L-arginine on the blood pressure of pitted normotensive and spontaneously hypertensive rats. Clin Exp Hypertens A Theory Practice. 14:1992;527-546.
17. Tippins JR CGRP: a neuropeptide from the calcitonin gene is the most potent vasodilator known. J Hypertens. 4:1986;S102-S105.
18. Wimalawansa SJ Effects of neonatal capsaicin therapy on plasma contents and tissue levels of immunoreactive-CGRP. Peptides. 14:1993;247-252.
19. Wimalawansa SJ Anti-hypertensive effects of oral calcium supplementation is mediated through the potent vasodilator CGRP. Am J Hypertension. 6:1993;996-1002.
20. Wimalawansa SJ Calcitonin gene-related peptide: molecular genetics, physiology, pathology and therapeutic potentials. Endocr Rev. 17:1996;533-585.
21. Wimalawansa SJ, MacIntyre I Heterogeneity of plasma calcitonin gene-related peptide: partial characterization of immunoreactive forms. Peptides. 9:1988;407-410.
22. Wimalawansa SJ, MacIntyre I Calcitonin gene-related peptide and its specific binding sites in the cardiovascular system of the rat. Int J Cardiol. 20:1988;29-37.
23. Wimalawansa SJ, Emson PC, MacIntyre I Regional distribution of calcitonin gene-related peptide and its specific binding sites in the rat, with particular reference to the nervous system. Neuroendocrinology. 46:1987;131-136.
24. Wimalawansa SJ, Morris HR, MacIntyre I Both α- and β-calcitonin gene-related peptides are present in plasma, cerebrospinal fluid and spinal cord in man. J Mol Endocrinol. 3:1989;247-252.
25. Yallampalli C, Garfield RE Inhibition of nitric oxide synthesis in rats during pregnancy produces symptoms identical to preeclampsia. Am J Obstet Gynecol. 169:1993;1316-1320.
26. Yallampalli C, Dong YL, Wimalawansa SJ Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-L-arginine methyl ester. Hum Reprod. 11:1996;895-899.